# SGSM3

## Overview
SGSM3, or small G protein signaling modulator 3, is a gene that encodes a protein involved in the regulation of small GTPases, which are pivotal for intracellular signaling pathways. The protein encoded by SGSM3 is primarily active in the cytoplasm and plays a significant role in modulating the activity of small GTPases, influencing processes such as vesicle trafficking, cytoskeletal dynamics, and cell growth (Jung2020Small). SGSM3 interacts with proteins in the Rab and Ras families, particularly affecting vesicle trafficking through its interaction with Ras-related protein Rab-8A, and is regulated by the C9orf72-SMCR8 complex (Dickson2019Extensive). The gene's expression levels have been linked to survival outcomes in disease models, underscoring its importance in cellular homeostasis and potential clinical significance in conditions such as myocardial infarction and neurodegenerative diseases (Jung2020Small; Dickson2019Extensive).

## Function
SGSM3 (small G protein signaling modulator 3) is involved in the regulation of small GTPases, which are essential for intracellular signaling pathways. These GTPases play a critical role in processes such as vesicle trafficking, cytoskeletal dynamics, and cell growth. SGSM3 modulates the activity of these GTPases, influencing cellular communication and function. It is primarily active in the cytoplasm, where it interacts with other proteins to facilitate these processes (Jung2020Small).

In the context of vesicular transport, SGSM3 interacts with Ras-related protein Rab-8A, a small Rab-GTPase, and is regulated by the C9orf72-SMCR8 complex. This interaction suggests that SGSM3 is involved in vesicle trafficking, potentially offering protective effects in certain disease contexts (Dickson2019Extensive). The gene's expression levels have been linked to survival outcomes in disease models, indicating its importance in cellular homeostasis and organismal health (Dickson2019Extensive).

SGSM3's role in healthy human cells is not extensively detailed in the available literature, but its involvement in fundamental cellular processes suggests it is crucial for maintaining normal cellular functions and responses to environmental changes.

## Clinical Significance
SGSM3 has been implicated in various diseases and conditions due to its role in cellular signaling pathways. In the context of myocardial infarction, SGSM3 interacts with Connexin 43 (Cx43) in rat mesenchymal stem cells (MSCs) under hypoxic conditions. Knockdown of SGSM3 in these cells has been shown to inhibit apoptosis and cardiomyocyte differentiation, suggesting its potential therapeutic implications for heart diseases (Jung2020Small).

In neurological disorders, SGSM3 expression levels have been associated with survival in C9orf72 expansion carriers, a condition linked to neurodegenerative diseases. Lower expression levels of SGSM3 correlate with shorter survival times, indicating its potential as a biomarker for disease progression (Dickson2019Extensive).

SGSM3 has also been identified as a gene with potential pleiotropic effects, influencing both psychiatric and immune-mediated diseases such as schizophrenia and inflammatory bowel diseases. It may act as a proxy for other gene-disease associations, suggesting a complex role in these conditions (Ellinghaus2021Crosstissue).

Additionally, SGSM3 is enriched in rare variants associated with disease, highlighting its clinical significance in genetic studies (Alhuzimi2017Properties).

## Interactions
SGSM3 (small G protein signaling modulator 3) is involved in modulating small GTPase signaling pathways, particularly through its interactions with proteins in the Rab and Ras families. These small GTPases are crucial for intracellular trafficking and signal transduction. SGSM3 has been identified as a potential modifier of survival in patients with C9orf72-related diseases, where it interacts with Ras-related protein Rab-8A, a small Rab-GTPase regulated by the C9orf72-SMCR8 complex. This interaction suggests a role for SGSM3 in vesicle trafficking processes, which are significantly affected by C9orf72 repeat expansions (Dickson2019Extensive).

The study by Dickson et al. highlights the importance of SGSM3 in the context of C9orf72 expansion carriers, showing that higher expression levels of SGSM3 are associated with prolonged survival after disease onset. This suggests that SGSM3 may have protective effects in these patients, potentially through its interactions with Rab-8A and involvement in vesicular transport processes (Dickson2019Extensive). The modulation of these interactions could serve as a therapeutic target or biomarker for disease progression in C9orf72-related conditions.


## References


[1. (Alhuzimi2017Properties) Eman Alhuzimi, Luis G. Leal, Michael J.E. Sternberg, and Alessia David. Properties of human genes guided by their enrichment in rare and common variants. Human Mutation, 39(3):365–370, December 2017. URL: http://dx.doi.org/10.1002/humu.23377, doi:10.1002/humu.23377. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23377)

[2. (Jung2020Small) Seung Eun Jung, Jung-Won Choi, Hanbyeol Moon, Sena Oh, Soyeon Lim, Seahyoung Lee, Sang Woo Kim, and Ki-Chul Hwang. Small g protein signaling modulator 3 (sgsm3) knockdown attenuates apoptosis and cardiogenic differentiation in rat mesenchymal stem cells exposed to hypoxia. PLOS ONE, 15(4):e0231272, April 2020. URL: http://dx.doi.org/10.1371/journal.pone.0231272, doi:10.1371/journal.pone.0231272. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0231272)

[3. (Dickson2019Extensive) Dennis W. Dickson, Matthew C. Baker, Jazmyne L. Jackson, Mariely DeJesus-Hernandez, NiCole A. Finch, Shulan Tian, Michael G. Heckman, Cyril Pottier, Tania F. Gendron, Melissa E. Murray, Yingxue Ren, Joseph S. Reddy, Neill R. Graff-Radford, Bradley F. Boeve, Ronald C. Petersen, David S. Knopman, Keith A. Josephs, Leonard Petrucelli, Björn Oskarsson, John W. Sheppard, Yan W. Asmann, Rosa Rademakers, and Marka van Blitterswijk. Extensive transcriptomic study emphasizes importance of vesicular transport in c9orf72 expansion carriers. Acta Neuropathologica Communications, October 2019. URL: http://dx.doi.org/10.1186/s40478-019-0797-0, doi:10.1186/s40478-019-0797-0. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40478-019-0797-0)

4. (Ellinghaus2021Crosstissue) Cross-tissue transcriptome-wide association studies of 885,176 individuals and seven diseases of the gut-brain axis identify susceptibility genes shared between schizophrenia and inflammatory bowel disease. This article has 0 citations.